Company Overview

Development Stage

About the Company

北京范恩柯尔生物科技有限公司成立于2019年,是一家由海外科学家创办、致力于抗癌新药研发为主要业务的初创公司。专注于靶向信号通路和免疫治疗的药物研发,包括具有自主知识产权的小分子靶向药物,大分子蛋白和抗体药物。研发项目基于国内国际的临床需求,具有完善的国内和国际知识产权保障。

范恩柯尔有资深的管理团队,是以科学严谨的态度为宗旨的研发公司,管理团队成员都有20年以上的国内和国外的研发管理经验。公司目前的研发项目是过去20年研发项目的延伸和拓展。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

范恩柯尔 Financing History (1 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 数千万人民币
  • Investor: 和诚资本,华盈健康,仁熙基...

范恩柯尔 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

范恩柯尔 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 408.4066万(元)
Legal Representative: 习宁
Date Established:
Credit Code: 91110302MA01P83M5J
Registered Address: 中山市火炬开发区健康路1号十三楼13-024室

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates